english: As of 2017, the drug is in phase III clinical trials for acne vulgaris and phase II clinical trials for androgenic alopecia.
non_english: Minangka 2017, tamba kasebut ana ing uji coba klinis tahap III kanggo acne vulgaris lan uji klinis tahap II kanggo alopecia androgenik.